Hjem
Tomas Mikal Lind Eagans bilde

Tomas Mikal Lind Eagan

Professor
  • E-postTomas.Eagan@uib.no
  • Besøksadresse
    3 etg Sentralblokken, Lungefløyen
    Jonas Lies vei 65
    5021 Bergen
    Rom 
    3077
  • Postadresse
    Postboks 7804
    5020 Bergen

Medisinstudenter ved Universitet i Bergen i andre og fjerde termin av Indremedisin.

  • Vis forfatter(e) 2021. The pulmonary mycobiome—A study of subjects with and without chronic obstructive pulmonary disease. PLOS ONE.
  • Vis forfatter(e) 2021. Exploring protocol bias in airway microbiome studies: one versus two PCR steps and 16S rRNA gene region V3 V4 versus V4. BMC Genomics.
  • Vis forfatter(e) 2021. CT-defined emphysema in COPD patients and risk for change in desaturation status in 6-min walk test. Respiratory Medicine.
  • Vis forfatter(e) 2020. One Year Change in 6-Minute Walk Test Outcomes is Associated with COPD Prognosis. COPD: Journal of Chronic Obstructive Pulmonary Disease. 662-671.
  • Vis forfatter(e) 2020. Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD. European Respiratory Journal.
  • Vis forfatter(e) 2020. Incremental costs of COPD exacerbations in GOLD stage 2+ COPD in ever-smokers of a general population. Respiratory Medicine: X. 1-7.
  • Vis forfatter(e) 2020. ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF. BMJ Open Respiratory Research.
  • Vis forfatter(e) 2020. Complications and discomfort after research bronchoscopy in the MicroCOPD study. BMJ Open Respiratory Research.
  • Vis forfatter(e) 2020. Coagulation markers as predictors for clinical events in COPD. Respirology (Carlton South. Print). 1-10.
  • Vis forfatter(e) 2020. Changes in the induced sputum proteome during COPD exacerbations. European Respiratory Journal.
  • Vis forfatter(e) 2019. The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease. PLOS ONE. 1-17.
  • Vis forfatter(e) 2019. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLOS ONE. 1-18.
  • Vis forfatter(e) 2019. Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study. Respiratory Medicine. 81-88.
  • Vis forfatter(e) 2019. Motivation and response rates in bronchoscopy studies. Multidisciplinary Respiratory Medicine. 1-9.
  • Vis forfatter(e) 2019. Laboratory contamination in airway microbiome studies. BMC Microbiology. 1-13.
  • Vis forfatter(e) 2019. Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 224-233.
  • Vis forfatter(e) 2019. Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels. European Respiratory Journal.
  • Vis forfatter(e) 2018. Tidal Expiratory Flow Limitation: A new method for evaluating pulmonary function in elderly and patients with Chronic Obstructive Pulmonary Disease .
  • Vis forfatter(e) 2018. Lung hyperinflation and functional exercise capacity in patients with COPD - a three-year longitudinal study. BMC Pulmonary Medicine. 9 sider.
  • Vis forfatter(e) 2018. Guideline adherence in hospital recruited and population based COPD patients. BMC Pulmonary Medicine. 1-9.
  • Vis forfatter(e) 2017. The association of tidal EFL with exercise performance, exacerbations, and death in COPD. The International Journal of Chronic Obstructive Pulmonary Disease. 2179-2188.
  • Vis forfatter(e) 2017. Static hyperinflation and decline in functional capacity in COPD patients. European Respiratory Journal.
  • Vis forfatter(e) 2017. Repeated desaturation in 6 minute walk test increases risk for mortality in COPD patients.
  • Vis forfatter(e) 2017. Protected sampling is preferable in bronchoscopic studies of the airway microbiome. European Respiratory Journal Open Research (ERJ Open Research).
  • Vis forfatter(e) 2017. Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients. PLOS ONE. 1-13.
  • Vis forfatter(e) 2017. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD. European Respiratory Journal. 1-10.
  • Vis forfatter(e) 2017. Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients. Respiratory Research. 1-9.
  • Vis forfatter(e) 2017. Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. European Respiratory Journal. 1-12.
  • Vis forfatter(e) 2017. A pilot study of hot-wire, ultrasonic and wedge-bellows spirometer inter- and intra-variability. BMC Research Notes.
  • Vis forfatter(e) 2016. Vitamin D and antimicrobial peptides in COPD. Results from the Bergen COPD Cohort Study.
  • Vis forfatter(e) 2016. Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. Respiratory Medicine. 53-59.
  • Vis forfatter(e) 2016. Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD. European Respiratory Journal.
  • Vis forfatter(e) 2016. Participation in research bronchoscopy: a literature review. European Clinical Respiratory Journal.
  • Vis forfatter(e) 2016. Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD patients. European Respiratory Journal. 82-91.
  • Vis forfatter(e) 2016. Macrophage migration inhibitory factor, a role in COPD. American Journal of Physiology - Lung cellular and Molecular Physiology. L1-L7.
  • Vis forfatter(e) 2016. Longitudinal changes in Peak Oxygen Uptake in Chronic Obstructive Pulmonary Disease (COPD) Patients with Dynamic Hyperinflation and/or Tidal Expiratory Flow Limitation.
  • Vis forfatter(e) 2016. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. The International Journal of Chronic Obstructive Pulmonary Disease. 2099-2108.
  • Vis forfatter(e) 2016. Expert opinion of mediastinal lymph node positions from an intrabronchial view. BMC Pulmonary Medicine.
  • Vis forfatter(e) 2016. Diffusion capacity and CT measures of emphysema and airway wall thickness – relation to arterial oxygen tension in COPD patients. European Clinical Respiratory Journal.
  • Vis forfatter(e) 2016. Complications and discomfort of bronchoscopy: a systematic review. European Clinical Respiratory Journal. 9 sider.
  • Vis forfatter(e) 2016. Change in Pulmonary Diffusion Capacity in a General Population Sample over 9 Years. European Clinical Respiratory Journal. 9 sider.
  • Vis forfatter(e) 2016. Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population. Clinical Respiratory Journal. 31-39.
  • Vis forfatter(e) 2015. Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD. PLOS ONE.
  • Vis forfatter(e) 2015. Variability of within-breath reactance in COPD patients and its association with dyspnoea. European Respiratory Journal. 625-634.
  • Vis forfatter(e) 2015. Serial measurements of arterial oxygen tension are associated with mortality in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease. 287-294.
  • Vis forfatter(e) 2015. Peak oxygen uptake and breathing pattern in COPD patients – a four year longitudinal study.
  • Vis forfatter(e) 2015. Peak oxygen uptake and breathing pattern in COPD patients - a four-year longitudinal study. BMC Pulmonary Medicine.
  • Vis forfatter(e) 2014. The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences. European Clinical Respiratory Journal.
  • Vis forfatter(e) 2014. Productivity losses in chronic obstructive pulmonary disease: a population-based survey. BMJ Open Respiratory Research. 1-8.
  • Vis forfatter(e) 2014. Predictors of exacerbations in chronic obstructive pulmonary disease - results from the Bergen COPD Cohort Study. PLOS ONE.
  • Vis forfatter(e) 2014. Predictors for PaO2 and hypoxemic respiratory failure in COPD-A three-year follow-up. COPD: Journal of Chronic Obstructive Pulmonary Disease. 531-538.
  • Vis forfatter(e) 2014. Physical activity and longitudinal change in 6-min walk distance in COPD patients. Respiratory Medicine. 86-94.
  • Vis forfatter(e) 2014. Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease. Respirology (Carlton South. Print). 730-734.
  • Vis forfatter(e) 2014. Mortality In COPD Patients With Increased Intrabreath Reactance.
  • Vis forfatter(e) 2014. Longitudinal change in peak oxygen uptake in COPD patients .
  • Vis forfatter(e) 2014. Longitudinal change in peak oxygen uptake in COPD patients .
  • Vis forfatter(e) 2014. Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. European Respiratory Journal.
  • Vis forfatter(e) 2014. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy. BMC Pulmonary Medicine.
  • Vis forfatter(e) 2014. Flow limitation during resting breathing is associated with reduced exercise capability in COPD.
  • Vis forfatter(e) 2014. Dynamic hyperinflation and respiratory timing during incremental exercise in patients with chronic obstructive pulmonary disease .
  • Vis forfatter(e) 2014. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. Respiratory Research.
  • Vis forfatter(e) 2014. Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients. Physiological Reports.
  • Vis forfatter(e) 2013. Slope and curvature of the relationship between ventilation and tidal volume in COPD patients.
  • Vis forfatter(e) 2013. Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clinical Respiratory Journal. 245-252.
  • Vis forfatter(e) 2013. Non-response in telephone surveys of COPD patients does not introduce bias. Journal of Telemedicine and Telecare. 40-44.
  • Vis forfatter(e) 2013. Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. Sleep Medicine. 1328-1333.
  • Vis forfatter(e) 2013. Comparison of 2011 and 2007 global initiative for chronic obstructive lung disease guidelines for predicting mortality and hospitalization. American Journal of Respiratory and Critical Care Medicine. 51-59.
  • Vis forfatter(e) 2013. Can intra-breath variations of reactance predict dyspnea?
  • Vis forfatter(e) 2012. The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. Respiratory Medicine. 361-366.
  • Vis forfatter(e) 2012. TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients. Respiratory Research. 10 sider.
  • Vis forfatter(e) 2012. Recommendations for epidemiological studies on COPD. European Respiratory Journal. 1278-1279.
  • Vis forfatter(e) 2012. Predictors for longitudinal change in 6-Minute Walk Distance in COPD patients.
  • Vis forfatter(e) 2012. Longitudinal Variability Of Expiratory Flow Limitation (EFL) In COPD Patients And Healthy Smokers Detected Non-invasively By Impulse Oscillometry.
  • Vis forfatter(e) 2012. Hu antibodies are present in smokers with chronic obstructive pulmonary disease without cancer or neurological disease. Journal of Neuroimmunology. 21-22.
  • Vis forfatter(e) 2012. Explained variance for blood gases in a population with COPD. Clinical Respiratory Journal. 72-80.
  • Vis forfatter(e) 2012. Exacebation history in COPD patients with and without expiratory flow limitation (EFL).
  • Vis forfatter(e) 2012. Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. COPD: Journal of Chronic Obstructive Pulmonary Disease. 227-234.
  • Vis forfatter(e) 2012. Daytime respiratory symptoms are associated with obstructive sleep apnoea syndrome. Journal of Sleep Research. 229-230.
  • Vis forfatter(e) 2012. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLOS ONE. 8 sider.
  • Vis forfatter(e) 2012. Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults. Respirology (Carlton South. Print). 499-505.
  • Vis forfatter(e) 2011. Recommendations for epidemiological studies on COPD. European Respiratory Journal. 1261-1277.
  • Vis forfatter(e) 2011. High prevalence of respiratory symptoms during air travel in patients with COPD. Respiratory Medicine. 50-56.
  • Vis forfatter(e) 2011. Expiratory flow limitation (EFL) detected non-invasively as a phenotypic characteristic of COPD.
  • Vis forfatter(e) 2011. Comorbidity of Asthma With ADHD. Journal of Attention Disorders. 564-571.
  • Vis forfatter(e) 2011. Adult attention deficit hyperactivity disorder is associated with asthma. BMC Psychiatry. 7 sider.
  • Vis forfatter(e) 2011. A randomised trial of endobronchial ultrasound guided sampling in peripheral lung lesions. Lung Cancer. 219-225.
  • Vis forfatter(e) 2011. 6 minutts gangtest hos KOLS-pasienter.
  • Vis forfatter(e) 2010. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respiratory Medicine. 283-290.
  • Vis forfatter(e) 2010. Systemic inflammatory markers in chronic obstructive pulmonary disease – results from the Bergen COPD Cohort Study. European Respiratory Journal. 540-548.
  • Vis forfatter(e) 2010. Socioeconomic risk factors for lung function decline in a general population. European Respiratory Journal. 480-487.
  • Vis forfatter(e) 2010. Significance of endobronchial lesion appearance in the diagnostic value of different endoscopic techniques Response. Respiratory Medicine. 1387-1387.
  • Vis forfatter(e) 2010. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health and Quality of Life Outcomes.
  • Vis forfatter(e) 2010. Reference values for resistance and reactance measures from Impuls Oscillometry in healthy elderly.
  • Vis forfatter(e) 2010. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. American Journal of Respiratory and Critical Care Medicine. 353-359.
  • Vis forfatter(e) 2010. Neutrophil Gelatinase-Associated Lipocalin A Biomarker in COPD. Chest. 888-895.
  • Vis forfatter(e) 2010. In-flight respiratory symptoms and pre-flight characteristics in patients with COPD.
  • Vis forfatter(e) 2010. Body composition and plasma levels of inflammatory biomarkers in COPD. European Respiratory Journal. 1027-1033.
  • Vis forfatter(e) 2010. Air travel habits in patients with COPD.
  • Vis forfatter(e) 2009. Within-day repeatability and signal to noise ratio for IOS parameters and FEV1 in smokers with and without COPD.
  • Vis forfatter(e) 2009. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respiratory Medicine. 283-290.
  • Vis forfatter(e) 2009. Quantitative CT Measures of Emphysema and Airway Wall Thickness Are Related to Respiratory Symptoms. American Journal of Respiratory and Critical Care Medicine.
  • Vis forfatter(e) 2009. Occupational exposure and incidence of respiratory disorders in a general population. Scandinavian Journal of Work, Environment and Health. 454-460.
  • Vis forfatter(e) 2009. Cost minimization analysis for combinations of sampling techniques in bronchoscopy of endobronchial lesions. Respiratory Medicine. 888-894.
  • Vis forfatter(e) 2008. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respiratory Medicine. 399-406.
  • Vis forfatter(e) 2008. Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques. BMC Pulmonary Medicine.
  • Vis forfatter(e) 2007. JEM-based occupational exposure assessment and incidence of respiratory disorders in a community sample.
  • Vis forfatter(e) 2007. Changes in Respiratory Symptoms and Health-Related Quality of Life. Chest. 1890-1897.

Se fullstendig oversikt over publikasjoner i CRIStin.

 1.      Eagan, T. M., Bakke, P. S., Eide, G. E. & Gulsvik, A. Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. Eur Respir J19, 599-605 (2002).

2.      Eagan, T., Eide, G., Gulsvik, A. & Bakke, P. Nonresponse in a community cohort study. Predictors and consequences for exposure-disease associations. J Clin Epidemiol 55, 775-781 (2002).

3.      Eagan, T. M., Gulsvik, A., Eide, G. E. & Bakke, P. S. Occupational airborne exposure and the incidence of respiratory symptoms and asthma. Am J Respir Crit Care Med 166, 933-938 (2002).

4.      Eagan, T. M., Gulsvik, A., Eide, G. E. & Bakke, P. S. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. Eur Respir J 23, 589-594 (2004).

5.      Eagan, T. M., Gulsvik, A., Eide, G. E. & Bakke, P. S. The effect of educational level on the incidence of asthma and respiratory symptoms. Respir Med 98, 730-736 (2004).

6.      Brøgger, J., Eagan, T., Eide, G. E., Bakke, P. & Gulsvik, A. Bias in retrospective studies of trends in asthma incidence. Eur Respir J 23, 281-286 (2004).

7.      Skorge, T. D., Eagan, T. M., Eide, G. E., Gulsvik, A. & Bakke, P. S. The Adult Incidence of Asthma and Respiratory Symptoms by Passive Smoking in Utero or Childhood. Am J Respir Crit Care Med (2005).

8.      Eagan, T. M., Brogger, J. C., Eide, G. E. & Bakke, P. S. The incidence of adult asthma: a review. Int J Tuberc Lung Dis 9, 603-612 (2005).

9.      Skorge, T. D., Eagan, T. M., Eide, G. E., Gulsvik, A. & Bakke, P. S. Indoor exposures and respiratory symptoms in a Norwegian community sample. Thorax 60, 937-942 (2005).

10.    Eagan, T. M., Hetland, J. & Aaro, L. E. Decline in respiratory symptoms in service workers five months after a public smoking ban. Tob Control 15, 242-246 (2006).

11.    Skorge, T. D., Eagan, T. M., Eide, G. E., Gulsvik, A. & Bakke, P. S. Exposure to environmental tobacco smoke in a general population. Respir Med 101, 277-285 (2007).

12.    Voll-Aanerud, M., Eagan, T. M., Wentzel-Larsen, T., Gulsvik, A. & Bakke, P. S. Changes in respiratory symptoms and health-related quality of life. Chest 131, 1890-1897 (2007).

13.    Roth, K., Hardie, J. A., Andreassen, A. H., Leh, F. & Eagan, T. M. Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques. BMC Pulm Med 8, 2 (2008).

14.    Voll-Aanerud, M., Eagan, T. M., Wentzel-Larsen, T., Gulsvik, A. & Bakke, P. S. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med 102, 399-406 (2008).

15.    Roth, K., Hardie, J. A., Andreassen, A. H., Leh, F. & Lind Eagan, T. M. Cost minimization analysis for combinations of sampling techniques in bronchoscopy of endobronchial lesions. Respir Med 103, 888-894 (2009).

16.    Skorge, T. D., Eagan, T. M., Eide, G. E., Gulsvik, A. & Bakke, P. S. Occupational exposure and incidence of respiratory disorders in a general population. Scand J Work Environ Health 35, 454-461 (2009).

17.    Eagan, T. M. et al. Systemic inflammatory markers in chronic obstructive pulmonary disease - results from the Bergen COPD Cohort Study. Eur Respir J 35, 540-548 (2010).

18.    Voll-Aanerud, M. et al. Respiratory symptoms in adults are related to impaired Quality of Life, regardless of asthma and COPD. Results from the European Community Respiratory Health Survey. Health and Quality of Life Outcomes 8, 107 (2010).

19.    Grydeland, T. B. et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med 181, 353-359 (2010).

20.    Fasmer, O. B. et al. Comorbidity of Asthma With ADHD. J Atten Disord (2010).

21.    Eagan, T. M. et al. Neutrophil Gelatinase Associated Lipocalin - a biomarker in Chronic Obstructive Pulmonary Disease. Chest 138, 888-895 (2010).

22.    Eagan, T. M. et al. Body composition and plasma levels of inflammatory biomarkers in COPD. Eur Respir J 36, 1027-1033 (2010).

23.    Johannessen, A., Eagan, T. M., Omenaas, E. R., Bakke, P. S. & Gulsvik, A. Socioeconomic risk factors for lung function decline in a general population. Eur Respir J 36, 480-487 (2010).

24.    Roth, K., Eagan, T. M., Andreassen, A. H., Leh, F. & Hardie, J. A. A randomised trial of endobronchial ultrasound guided sampling in peripheral lung lesions. Lung Cancer (2011).

25.    Saure, E. W. et al. Explained variance for blood gases in a population with COPD. Clin Respir J (2011).

26.    Fasmer, O. B., Halmoy, A., Eagan, T. M., Oedegaard, K. J. & Haavik, J. Adult attention deficit hyperactivity disorder is associated with asthma. BMC Psychiatry 11, 128 (2011).

27.    Bakke, P. S. et al. Recommendations for epidemiological studies on COPD. Eur Respir J 38, 1261-1277 (2011).

28.    Edvardsen, A. et al. High prevalence of respiratory symptoms during air travel in patients with COPD. Respir Med 105, 50-56 (2011).

29.    Gjerde, B., Bakke, P. S., Ueland, T., Hardie, J. A. & Eagan, T. M. The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. Respir Med (2011).

30.    Persson, L. P. J. et al. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One 7, :338934 (2012).

31.    Johannessen, A., Bakke, P. S., Hardie, J. A. & Eagan, T. M. Association of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adults. Respirology 17, 499-505 (2012).

32.    Aarli, B. B., Eagan, T. M., Ellingsen, I., Bakke, P. S. & Hardie, J. A. Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clin Respir J (2012).

33.    Waatevik, M. et al. Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. COPD 9, 227-234 (2012).

34.    Eagan, T. M. et al. TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients. Respir Res 13, 48 (2012).

35.    Johannessen, A. et al. Comparison of 2011 and 2007 GOLD Guidelines for Predicting Mortality and Hospitalization. Am J Respir Crit Care Med (2013).

36.    Hynninen, M. J. et al. Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. Sleep Med 14, 1328-1333 (2013).

37.    Aanerud, M., Braut, H., Wentzel-Larsen, T., Eagan, T. M. & Bakke, P. S. Non-response in telephone surveys of COPD patients does not introduce bias. J Telemed Telecare (2013).

38.    Olfert, I. M., Malek, M. H., Eagan, T. M., Wagner, H. & Wagner, P. D. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients ‘on’ or ‘off’ augmentation therapy. BMC Pulm Med 14, 106 (2014).

39.    Husebo, G. R. et al. Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study. PLoS One 9, e109721 (2014).

40.    Qvale, T. H. et al. Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease. Respirology (2014).

41.    Frisk, B. et al. Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients. Physiol Rep 2, e00222 (2014).

42.    Frisk, B. et al. Physical activity and longitudinal change in 6-min walk distance in COPD patients. Respir Med 108, 86-94 (2014).

43.    Tangedal, S. et al. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. Respir Res 15, 138 (2014).

44.    Aarli, B. B. et al. Variability of within-breath reactance in COPD patients and its association with dyspnoea. Eur Respir J (2014).

45.    Saure, E. W. et al. Predictors for PaO2 and Hypoxemic Respiratory Failure in COPD-A Three-Year Follow-up. COPD 11, 531-538 (2014).

46.    Aanerud, M. et al. Serial Measurements of Arterial Oxygen Tension are Associated with Mortality in COPD. COPD (2014).

47.    Voll-Aanerud, M., Eagan, T., Wentzel-Larsen, T., Gulsvik, A. & Bakke, P. Asthma and health-related quality of life - effect of adjustment for potential confounders. The Clinical Respiratory Journal 2, 106-115 (2008).

48.    Eagan, T. M. et al. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respir Med 104, 283-290 (2010).

 

The Bergen COPD Microbiome Study (MikroKOLS)

The study aims to characterize the airways microbiome in patients with COPD, compared with healthy adults.

Secondary motives are to assess different bronchoscopic sampling techniques, to compare the microbiome within the lungs (upper versus lower airways, left versus right lung), and to study the impact of tobacco smoking and mody composition on the airways microbiome.

The pilot study was performed spring of 2012, data collection is well underway, and will be finalized by Summer of 2015.

Metagenomic sequencing is performed on the Illumina MiSeq platform.  

 

The lung microbiome in interstitial lung disease Study (MikroILS)

This is an extension of the MikroKOLS study, where we aim to characterize the airways microbiome in patients undergoing evaluation for interstitial lung diseases. The first patient was included in December 2014, planned project period is until end of 2016.

The Bergen GeneCOPD follow-up study (GenKOLS oppfølgingen)

The first Bergen GeneCOPD study was performed in 2002/04, where 500 COPD patients and healthy controls were assessed with a CT scan, lung function testing and clinical data, and genewide assosiation studies were performed. In 2014 the follow-up started, aiming to include 250 patients and 400 controls. Primaty study question is the assessment of longitudinal change in COPD assessed by CT thorax, secondary motive is to assess risk factors for comorbid coronary heart disease. 

The Bergen COPD Cohort Study (BergenKOLS)

The study started in 2006, and ended in 2014. More than 400 COPD patients and 300 healthy controls were included, and most were attempted followed until the end of 2014, with annual clinical examinations.

The main research question was to search for predictors of later advers outcomes such as mortality, exacerbation frequency, development of cachexia and lung function decline. Several papers are already published, and several more are underway.